Drugmaker Zydus Cadila mentioned on Friday it signed a non-exclusive settlement with Gilead Sciences Inc to fabricate and market antiviral drug remdesivir, the primary remedy to indicate enchancment in COVID-19 trials.
Listen to the latest songs, solely on JioSaavn.com
Comments
Discover more from News Journals
Subscribe to get the latest posts sent to your email.
